Skip to main content
. 2020 May 5;35:101738. doi: 10.1016/j.tmaid.2020.101738

Table 3.

Adverse events.

Patients without any adverse event 1036 (97.6%)
Patients with adverse events possibly related to the treatmenta 25 (2.4%)
Diarrhea 12
Abdominal pain 3
Headache 3
Nausea 2
Insomnia 2
Transient blurred vision 2
Vomiting 1
Urticaria 1
Erythematous and bullous rash 1
Discontinuation of treatment 3 (abdominal pain, urticaria, erythematous and bullous rash)
a

Some patients reported more than one adverse event.

HHS Vulnerability Disclosure